Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat Publisher Pubmed



Pourheydar B1, 2 ; Soleimani Asl S3, 4 ; Azimzadeh M5 ; Rezaei Moghadam A6 ; Marzban A7 ; Mehdizadeh M8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anatomical Sciences, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
  2. 2. Neurophysiology Research Center, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
  3. 3. Anatomy Department, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. Cell Therapy Division, Endometrium and Endometriosis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
  5. 5. Young Researchers and Elite Club, Islamic Azad University, Yazd Branch, Yazd, Iran
  6. 6. Faculty of Veterinary Medicine, Islamic Azad University, Tabriz Branch, Tabriz, Iran
  7. 7. Department of Pediatrics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  8. 8. Cellular and Molecular Research Center, Department of Anatomy, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran

Source: Behavioural Neurology Published:2016


Abstract

Cell therapy is the most advanced treatment of the cerebral ischemia, nowadays. Herein, we discuss the neuroprotective effects of bone marrow mesenchymal stem cells (BMSCs) on rat hippocampal cells following intravenous injection of these cells in an ischemia-reperfusion model. Adult male Wistar rats were divided into 5 groups: control, sham (surgery without blockage of common carotid arteries), ischemia (common carotid arteries were blocked for 30 min prior to reperfusion), vehicle (7 days after ischemia PBS was injected via the tail vein), and treatment (injections of BMSC into the tail veins 7 days after ischemia). We performed neuromuscular and vestibulomotor function tests to assess behavioral function and, finally, brains were subjected to hematoxylin and eosin (H&E), anti-Brdu immunohistochemistry, and TUNEL staining. The ischemia group had severe apoptosis. The group treated with BMSCs had a lower mortality rate and also had significant improvement in functional recovery (P<0.001). Ischemia-reperfusion for 30 min causes damage and extensive neuronal death in the hippocampus, especially in CA1 and CA3 regions, leading to several functional and neurological deficits. In conclusion, intravenous injection of BMSCs can significantly decrease the number of apoptotic neurons and significantly improve functional recovery, which may be a beneficial treatment method for ischemic injuries. © 2016 Bagher Pourheydar et al.